In July 2024, Checkpoint announced that the FDA accepted for review the resubmission of its BLA for cosibelimab as a complete ...

Announced collaboration agreements with Formosa Pharmaceuticals, Senju Pharmaceutical Co., Ltd. and SGN Nanopharma to develop novel therapeutics for use with Eyenovia's Optejet® dispenser as potential ...

Driven by curiosity and a desire to honor the vineyard's potential, she began making wine for her family and friends, ...